P442: SPINK2 PROTEIN EXPRESSION QUANTIFIED BY IMMUNOHISTOCHEMISTRY REFINES RISK STRATIFICATION AND PREDICTS THERAPY OUTCOMES IN AML
Main Authors: | H. A. Pitts, C. K. Cheng, J. S. Cheung, M. K. H. Sun, M. H. Ng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844656.93622.d3 |
Similar Items
-
SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response
by: Herbert Augustus Pitts, et al.
Published: (2023-06-01) -
<title language="por">Debate sobre o artigo de Mary Jane P. Spink Debate on the paper by Mary Jane P. Spink
by: Silvana Inés Weller
Published: (2001-12-01) -
Functional Roles of SPINK1 in Cancers
by: Tsung-Chieh Lin
Published: (2021-04-01) -
High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT
by: Tzu-Ju Chen, et al.
Published: (2021-06-01) -
P412: TRANSCRIPTOMIC CLASSIFICATION, RISK STRATIFICATION AND THERAPY SELECTION IN AML
by: Jeppe Severens, et al.
Published: (2023-08-01)